ABOUT GENETRON
'GENETRON' IS OUR ORIGIN,
OUR SPIRIT, OUR LEGACY.
Genetron Holdings Limited (“Genetron Health” or the “Company”) (Nasdaq: GTH) is a world-leading precision oncology platform company that specializes in research and application of cancer genomics, providing early screening, medication guidance, prognostic monitoring, and new cancer drug development services that cover the entire spectrum of cancer management. The company is committed to applying innovative genomics technology to cancer-related diagnosis and treatment, and ultimately defeating cancer.
AN ONCOLOGY PLATFORM
FOR TRANSFORMING CARE
- EARLY SCREENING
- DIAGNOSTICS & MONITORING
- BIOPHARMA SERVICES
THE GENETRON PLATFORM
01
BREAKTHROUGH SCIENCE
At Genetron, we firmly believe in using the best tools that science and technology has to offer for our work, and we hold ourselves to the most rigorous of international standards. From academic research to laboratory operations, precision insights require consistent and thorough processes.
02
PRECISION SOLUTIONS
Each patient’s journey through cancer is a fiercely personal experience. Whether it’s targeted treatment, continuous monitoring, or actionable guidance, Genetron’s precision solutions are crafted with an emphasis on personalization and participation—for patients and partners alike.
03
HUMAN-CENTERED CARE
Breakthrough innovations and the transformations they catalyze are enabled by a zeal for life and empathy for people. Genetron’s core values (B.R.A.V.E.) foster a culture that empowers each of us to navigate ambiguity and discover solutions anchored by the needs of those we serve.
INTERNATIONAL RECOGNITION
